We are live on ! Find out more
BHC icon

Bausch Health

452 hedge funds and large institutions have $36.9B invested in Bausch Health in 2014 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 140 increasing their positions, 188 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 30

25% more call options, than puts

Call options by funds: $721M | Put options by funds: $579M

14% more capital invested

Capital invested by funds: $32.4B → $36.9B (+$4.45B)

11% more funds holding

Funds holding: 409452 (+43)

0.95% more ownership

Funds ownership: 82.7%83.65% (+0.95%)

3% less funds holding in top 10

Funds holding in top 10: 6058 (-2)

26% less repeat investments, than reductions

Existing positions increased: 140 | Existing positions reduced: 188

Holders
452
Holders Change
+43
Holders Change %
+10.51%
% of All Funds
13.06%
Holding in Top 10
58
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-3.33%
% of All Funds
1.68%
New
77
Increased
140
Reduced
188
Closed
30
Calls
$721M
Puts
$579M
Net Calls
+$142M
Net Calls Change
-$47.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Adage Capital Partners
151
Adage Capital Partners
Massachusetts
$13.2M +$13.7M +100,000 New
Macquarie Group
152
Macquarie Group
Australia
$13M +$7.16M +52,390 +113%
VanEck Associates
153
VanEck Associates
New York
$13M -$1.16M -8,496 -8%
GIBU
154
Gulf International Bank (UK)
United Kingdom
$12.8M
1M
155
13D Management
New York
$12.7M +$3.82M +27,954 +41%
MRCM
156
M&R Capital Management
New Jersey
$12.1M +$769K +5,623 +7%
MME
157
Meag Munich Ergo
Germany
$12M +$1.44M +10,500 +13%
FTIOP
158
Fiduciary Trust International of Pennsylvania
Pennsylvania
$11.1M -$1.96M -14,365 -15%
SA
159
Steadfast Advisors
New York
$10.8M -$6.36M -46,538 -36%
WC
160
Wexford Capital
Florida
$10.6M +$11M +80,323 New
HSBC Holdings
161
HSBC Holdings
United Kingdom
$10.5M +$1.11M +8,151 +11%
Citigroup
162
Citigroup
New York
$10.5M -$7.15M -52,324 -40%
SCA
163
Southpoint Capital Advisors
New York
$10.2M +$10.5M +77,000 New
Los Angeles Capital Management
164
Los Angeles Capital Management
California
$10.1M +$10.1M +73,756 +2,732%
SCM
165
Suvretta Capital Management
New York
$10M +$10.4M +76,000 New
VCM
166
Vigilant Capital Management
Maine
$9.93M +$119K +870 +1%
PIM
167
Partner Investment Management
California
$9.81M +$9.91M +72,473 +3,696%
MSA
168
Mason Street Advisors
Wisconsin
$9.78M -$11.1M -81,516 -52%
AFG
169
Albion Financial Group
Utah
$9.38M +$73.4K +537 +0.8%
Stifel Financial
170
Stifel Financial
Missouri
$9.28M +$9.63M +70,426 New
IIM
171
Ivory Investment Management
New York
$9.05M -$3.83M -28,018 -29%
GXMC
172
Global X Management Company
New York
$8.98M +$9.32M +68,138 New
FNBOO
173
First National Bank of Omaha
Nebraska
$8.75M -$1.42M -10,386 -14%
LOAMU
174
Lombard Odier Asset Management (USA)
New York
$8.57M +$2.05M +15,000 +30%
IG
175
ING Group
Netherlands
$8.53M +$8.84M +64,642 New

BHC Hedge Fund Activity: Q1 2014 in Review

452 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Bausch Health (BHC) for Q1 2014, worth a combined $36.9B — up 14% from $32.4B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new BHC positions and 30 closed out — a net gain of 47 holders — while 140 added to existing stakes and 188 trimmed.

The largest buyer was Bank of Montreal, adding an estimated $412M. The largest seller was Fidelity Investments, cutting an estimated $443M.

  • 452 institutional investors held Bausch Health (BHC) as of Q1 2014, up from 409 in Q4 2013.
  • Funds reported $36.9B of Bausch Health stock for Q1 2014, up 14% quarter-over-quarter.
  • 77 funds opened new Bausch Health positions in Q1 2014 and 30 closed out, a net change of +47 holders.
  • The largest Bausch Health buyer in Q1 2014 was Bank of Montreal, an estimated $412M added.
  • The largest Bausch Health seller in Q1 2014 was Fidelity Investments, an estimated $443M sold.

Based on aggregated 13F filings for Q1 2014.